title: Telomere length in relation to immunological parameters in patients with renal cell carcinoma.
abstract: Over the last decade, telomere length (TL) has gained attention as a potential biomarker in cancer disease. We previously reported that long blood TL was associated with a poorer outcome in patients with breast cancer and renal cell carcinoma. Based on these findings, we hypothesized that certain immunological components may have an impact on TL dynamics in cancer patients. One aim of the present study was to investigate a possible association between serum cytokines and TL of peripheral blood cells, tumors and corresponding kidney cortex, in patients with clear cell renal cell carcinoma. For this purpose, a multiplex cytokine assay was used. Correlation analysis revealed significant positive correlations between tumor TL and peripheral levels of three cytokines (IL-7, IL-8 and IL-10). In a parallel patient group with various kidney tumors, TL was investigated in whole blood and in immune cell subsets in relation to peripheral levels of regulatory T cells (Tregs). A significant positive association was found between whole blood TL and Treg levels. However, the strongest correlation was found between Tregs and TL of the T lymphocyte fraction. Thus, patients with higher Treg levels displayed longer T cell telomeres, which might reflect a suppressed immune system with fewer cell divisions and hence less telomere shortening. These results are in line with our earlier observation that long blood TL is an unfavorable prognostic factor for cancer-specific survival. In summary, we here show that immunological components are associated with TL in patients with renal cell carcinoma, providing further insight into the field of telomere biology in cancer.
authors: Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
authors: Ulrika
authors: U
authors: Svenson
authors: Elisabeth
authors: E
authors: Grönlund
authors: Ingegerd
authors: I
authors: Söderström
authors: Raviprakash T
authors: RT
authors: Sitaram
authors: Börje
authors: B
authors: Ljungberg
authors: Göran
authors: G
authors: Roos
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics* / Q000276:immunology; D002292:Carcinoma, Renal Cell / Q000235:genetics* / Q000276:immunology; D016207:Cytokines / Q000097:blood; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D016753:Interleukin-10 / Q000097:blood; D015851:Interleukin-7 / Q000097:blood; D016209:Interleukin-8 / Q000097:blood; D007680:Kidney Neoplasms / Q000235:genetics* / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism; D016615:Telomere / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D016207:Cytokines; D015851:Interleukin-7; D016209:Interleukin-8; D016753:Interleukin-10
references: Blood. 2002 Jun 1;99(11):3892-904
references: 12010786
references: Cancer Res. 2009 Apr 1;69(7):2896-901
references: 19318563
references: Cell. 1985 Dec;43(2 Pt 1):405-13
references: 3907856
references: Int J Hematol. 2011 Jan;93(1):74-82
references: 21203871
references: J Physiol Pharmacol. 2008 Dec;59 Suppl 9:169-86
references: 19261979
references: Blood. 1997 Feb 15;89(4):1299-307
references: 9028953
references: Int J Cancer. 2006 Nov 15;119(10):2255-60
references: 16858685
references: J Immunol. 2005 May 1;174(9):5261-9
references: 15843522
references: Br J Cancer. 1999 Jan;79(1):119-30
references: 10408703
references: Chromosoma. 2006 Dec;115(6):413-25
references: 16741708
references: Cytokine Growth Factor Rev. 2001 Dec;12(4):375-91
references: 11544106
references: Microbiol Mol Biol Rev. 2002 Sep;66(3):407-25, table of contents
references: 12208997
references: J Exp Med. 1999 Jul 19;190(2):157-67
references: 10432279
references: Carcinogenesis. 2012 May;33(5):1040-5
references: 22318909
references: Br J Cancer. 1999 Mar;79(7-8):1182-4
references: 10098756
references: Exp Gerontol. 2009 May;44(5):363-6
references: 19248826
references: Biochem Biophys Res Commun. 2007 Jun 22;358(1):215-8
references: 17481586
references: Cancer Res. 2012 May 1;72(9):2162-71
references: 22549946
references: Eur J Cancer. 2004 Mar;40(4):494-502
references: 14962714
references: N Engl J Med. 1996 Sep 19;335(12):865-75
references: 8778606
references: Blood. 2003 Jun 15;101(12):4982-9
references: 12609839
references: Eur J Immunol. 1999 Nov;29(11):3745-53
references: 10556831
references: Eur Urol. 2009 Apr;55(4):851-63
references: 19155123
references: Mech Ageing Dev. 2009 Jan-Feb;130(1-2):86-91
references: 18555517
references: Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11091-4
references: 7479943
references: Semin Cancer Biol. 2007 Aug;17(4):330-43
references: 17656104
references: Cancer Immunol Immunother. 2007 Nov;56(11):1743-53
references: 17487490
references: Nat Med. 2004 Sep;10(9):942-9
references: 15322536
references: J Immunol. 2004 Jul 15;173(2):1444-53
references: 15240741
references: Cancer Res. 2002 Jul 1;62(13):3876-82
references: 12097303
references: PLoS One. 2011;6(6):e21485
references: 21720548
references: Cancer Res. 2005 Mar 15;65(6):2457-64
references: 15781662
references: Cancer Res. 2008 May 15;68(10):3618-23
references: 18483243
references: Arthritis Rheum. 2010 Feb;62(2):383-91
references: 20112361
references: Nat Biotechnol. 1998 Aug;16(8):743-7
references: 9702772
references: PLoS Genet. 2012;8(5):e1002696
references: 22661914
references: Clin Cancer Res. 2007 Apr 15;13(8):2385-91
references: 17438097
references: J Pathol. 1997 Oct;183(2):131-3
references: 9390023
references: J Immunol. 2002 Sep 1;169(5):2756-61
references: 12193750
references: Biochim Biophys Acta. 2009 Apr;1792(4):317-23
references: 19419696
references: Semin Cancer Biol. 2006 Feb;16(1):38-52
references: 16139507
references: Immunology. 2006 Oct;119(2):243-53
references: 17005004
references: J Cell Mol Med. 2011 Jun;15(6):1227-38
references: 21352473